Isogenica Limited Enters into Research and License Agreement with Wyeth
CAMBRIDGE, England,1st June 2007: Isogenica Ltd, today announced that it has entered into a research and license agreement with Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE).